FREE SHIPPING ON ORDERS OVER $150

klow-con and xeloda Adjuvant capecitabine in early-stage triple-negative breast cancer? Yes, but for whom? Cancer drug shortage is forcing

$21.26

Quantity
- +
Description

Plant growth-promoting rhizobacteria inoculation and nitrogen fertilization increase maize ( Zea mays L.) grain yield and modified rhizosphere microbial communities

klow-con and xeloda Adjuvant capecitabine in early-stage triple-negative breast cancer? Yes, but for whom? Cancer drug shortage is forcing

[DOI] [PMC free article] [PubMed] [Google Scholar] 36.Mohaghegh Shalmani L., Valian N., Pournajaf S., Abbaszadeh F., Dargahi L., Jorjani M

klow-con and xeloda Adjuvant capecitabine in early-stage triple-negative breast cancer? Yes, but for whom? Cancer drug shortage is forcing

A promising diagnostic option is the FR-targeted contrast-enhanced magnetic resonance imaging (MRI)

klow-con and xeloda Adjuvant capecitabine in early-stage triple-negative breast cancer? Yes, but for whom? Cancer drug shortage is forcing

Detection of hepatic oxidative stress can be an early indicator of hepatotoxicity and benefits

klow-con and xeloda Adjuvant capecitabine in early-stage triple-negative breast cancer? Yes, but for whom? Cancer drug shortage is forcing

You may also like

recommand products

BPC-157

US$ 22.25

Min. order: 1 piece

4.4 (20 reviews)

Sold : Login>>